russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLC10.15829/1560-4071-2021-4125russjcardiol-4125Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEWТранскатетерная хирургия резидуального стеноза пути оттока в легочную артериюTranscatheter surgery of residual right ventricular outflow tract stenosishttps://orcid.org/0000-0001-7254-0733РзаеваК. А.RzayevaK. A.

Аспирант центра новых хирургических технологий/

Новосибирск

Novosibirsk

ksusha.rzaeva@yandex.ruhttps://orcid.org/0000-0003-4017-4198ГорбатыхА. В.GorbatykhA. V.

Кандидат медицинских наук, зав. НИЛ эндоваскулярной хирургии института сердца, старший научный сотрудник.

Санкт-Петербург

St. Petersburg

a_gorbatyh@meshalkin.ruhttps://orcid.org/0000-0002-1935-4170ЖуравлеваИ. Ю.ZhuravlevaI. Yu.

Доктор медицинских наук, директор института экспериментальной биологии и медицины.

Новосибирск

Novosibirsk

zhuravleva_i@meshalkin.ruhttps://orcid.org/0000-0003-3691-2848СойновИ. А.SoinovI. A.

Кандидат медицинских наук, врач сердечно-сосудистый хирург кардиохирургического отделения врожденных пороков сердца.

Новосибирск

Novosibirsk

i_sojnov@meshalkin.ruhttps://orcid.org/0000-0003-3797-4899ВойтовА. В.VoitovA. V.

Врач сердечно-сосудистый хирург кардиохирургического отделения врожденных пороков сердца.

Новосибирск

Novosibirsk

a_vojtov@meshalkin.ruhttps://orcid.org/0000-0003-3234-5436АрхиповА. Н.ArkhipovA. N.

Кандидат медицинских наук, врач сердечно-сосудистый хирург, зав. отделением врожденных пороков сердца, старший научный сотрудник центра новых хирургических технологий.

Новосибирск

Novosibirsk

a_arkhipov@meshalkin.ruhttps://orcid.org/0000-0002-2361-5847КулябинЮ. Ю.KulyabinYu. Yu.

Кандидат медицинских наук, врач сердечно-сосудистый хирург кардиохирургического отделения врожденных пороков сердца.

Новосибирск

Novosibirsk

ju_kuljabin@meshalkin.ruhttps://orcid.org/0000-0003-4625-4631Богачев-ПрокофьевА. В.Bogachev-ProkofievA. V.

Доктор медицинских наук, директор института патологии кровообращения, врач сердечно-сосудистый хирург.

Новосибирск

Novosibirsk

a_bogachev@meshalkin.ruhttps://orcid.org/0000-0002-6204-5381ГорбатыхЮ. Н.GorbatykhYu. N.

Доктор медицинских наук, профессор, ведущий научный сотрудник центра новых хирургических технологий.

Санкт-Петербург

Novosibirsk

yng@meshalkin.ruhttps://orcid.org/0000-0001-9818-8678ЧернявскийА. М.ChernyavskyA. M.

Доктор медицинских наук, профессор, врач сердечно-сосудистый хирург, директор.

Новосибирск

Novosibirsk

a_cherniavsky@meshalkin.ruФГБУ НМИЦ им. акад. Е.Н. Мешалкина Минздрава РоссиРоссияMeshalkin National Medical Research CenterRussian FederationФГБУ НМИЦ им. В.А. Алмазова Минздрава РоссииРоссияAlmazov National Medical Research CenterRussian Federation20210409202126841254125Copyright © Рзаева К.А., Горбатых А.В., Журавлева И.Ю., Сойнов И.А., Войтов А.В., Архипов А.Н., Кулябин Ю.Ю., Богачев-Прокофьев А.В., Горбатых Ю.Н., Чернявский А.М., 20212021Рзаева К.А., Горбатых А.В., Журавлева И.Ю., Сойнов И.А., Войтов А.В., Архипов А.Н., Кулябин Ю.Ю., Богачев-Прокофьев А.В., Горбатых Ю.Н., Чернявский А.М.Rzayeva K.A., Gorbatykh A.V., Zhuravleva I.Y., Soinov I.A., Voitov A.V., Arkhipov A.N., Kulyabin Y.Y., Bogachev-Prokofiev A.V., Gorbatykh Y.N., Chernyavsky A.M.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/4125

В течение последних 40 лет разработаны различные виды протезов, используемых при реконструкции выходного отдела правого желудочка. Тем не менее стеноз и недостаточность кондуита вследствие дегенерации клапана возникают достаточно часто, что ограничивает продолжительность жизни пациентов. Транскатетерное стентирование кондуитов не всегда дает положительные результаты и может приводить к выраженной легочной регургитации. Новый метод чрескожной имплантации клапана легочной артерии является хорошей альтернативой хирургическому способу коррекции по отдаленным результатам выживаемости и качества жизни.

Over the past 40 years, various types of prostheses have been developed for right ventricular outflow tract reconstruction. However, conduit stenosis and insufficiency due to valve degeneration occur frequently, decreasing the lifetime of patients. Transcatheter stenting of conduits does not always give favorable results and can lead to severe pulmonary regurgitation. The novel method of percutaneous pulmonary valve implantation is a good alternative to the surgical intervention according to data on long-term survival and quality of life.

врожденный порок сердцавыходной отдел правого желудочкатранскатетерная имплантация легочного клапанаcongenital heart diseaseright ventricular outflow tracttranscatheter pulmonary valve implantationСтатья поддержана грантом 21-75-10041 Российского научного фонда (по мероприятию “Проведение исследований научными группами под руководством молодых ученых” Президентской программы исследовательских проектов, реализуемых ведущими учеными, в т.ч. молодыми учеными)This article was supported by the Russian Science Foundation grant 21-75-10041 (according to the event “Conducting research by scientific groups under the leadership of young scientists” of the Presidential Program of research projects implemented by leading scientists, including young scientists)ReferencesОмельченко А. Ю., Горбатых Ю. Н., Сойнов И. А. и др. Оценка функции правого желудочка после коррекции тетрады Фалло. Сибирский научный медицинский журнал. 2016;36(3):48-54.Omelchenko AY, Gorbatykh YN, Soynov IA, et al. Assessment of anatomical parts of the right ventricle in patients after tetralogy of fallot repair. Sibirskij Medicinskij Zurnal = Siberian Medical Journal. 2016;36(3):48-54. (In Russ.)Latus H, Hachmann P, Gummel K, et al. Impact of residual right ventricular outflow tract obstruction on biventricular strain and synchrony in patients after repair of tetralogy of Fallot: a cardiac magnetic resonance feature tracking study. Eur J Cardiothorac Surg. 2015;48(1):83-90. doi:10.1093/ejcts/ezu396.Latus H, Hachmann P, Gummel K, et al. Impact of residual right ventricular outflow tract obstruction on biventricular strain and synchrony in patients after repair of tetralogy of Fallot: a cardiac magnetic resonance feature tracking study. Eur J Cardiothorac Surg. 2015;48(1):83-90. doi:10.1093/ejcts/ezu396.Лукьянов А.А., Караськов А.М., Горбатых Ю.Н. и др. Ближайшие и отдаленные результаты операции Росса у пациентов педиатрической группы. Патология кровообращения и кардиохирургия. 2014;2:5-9.Lukyanov AA, Karaskov AM, Gorbatyh YuN, et al. Immediate postoperative results and long-term outcome after Ross procedure among the pediatric population. Patologiya krovoobrashcheniya i kardiokhirurgiya = Circulation Pathology and Cardiac Surgery. 2014;2:5-9. (In Russ.)Lock J, Niemi T, Einzing S, et al. Transvenous angioplasty of experimental branch pulmonary artery stenosis in newborn lambs. Circulation. 1981;64:886-93. doi:10.1016/1058-9813(92)90037-M.Lock J, Niemi T, Einzing S, et al. Transvenous angioplasty of experimental branch pulmonary artery stenosis in newborn lambs. Circulation. 1981;64:886-93. doi:10.1016/1058-9813(92)90037-M.Holzer R, Gauvreau K, Kreutzer J, et al. Balloon angioplasty and stenting of branch pulmonary arteries: adverse events and procedural characteristics: results of a multi-institutional registry. Circ Cardiovasc Interv. 2011;4(3):287-96. doi:10.1161/CIRCINTERVENTIONS.110.961029.Holzer R, Gauvreau K, Kreutzer J, et al. Balloon angioplasty and stenting of branch pulmonary arteries: adverse events and procedural characteristics: results of a multi-institutional registry. Circ Cardiovasc Interv. 2011;4(3):287-96. doi:10.1161/CIRCINTERVENTIONS.110.961029.Kan J, White R, Mitchell S, et al. Percutaneous balloon valvuloplasty: a new method for treating congenital pulmonary valve stenosis. N Engl J Med. 1982;307:540-2. doi:10.1056/NEJM198208263070907.Kan J, White R, Mitchell S, et al. Percutaneous balloon valvuloplasty: a new method for treating congenital pulmonary valve stenosis. N Engl J Med. 1982;307:540-2. doi:10.1056/NEJM198208263070907.Gentles T, Lock J, Perry S. High pressure balloon angioplasty of pulmonary artery stenosis. Am J Coll Cardiol. 1992;19. doi:10.1016/0735-1097(93)90205-f.Gentles T, Lock J, Perry S. High pressure balloon angioplasty of pulmonary artery stenosis. Am J Coll Cardiol. 1992;19. doi:10.1016/0735-1097(93)90205-f.Rocchini A. Balloon angioplasty for peripheral pulmonary stenosis. In: Transcatheter therapy in pediatric cardiology. Editor Rao P.S. New York. 1993:213-29.Rocchini A. Balloon angioplasty for peripheral pulmonary stenosis. In: Transcatheter therapy in pediatric cardiology. Editor Rao P.S. New York. 1993:213-29.Palmaz J, Sibbitt R, Reuter S, et al. Expandable intraluminal graft: a preliminary study: work in progress. Radiology. 1985:156;73-7. doi:10.1148/radiology.156.1.3159043.Palmaz J, Sibbitt R, Reuter S, et al. Expandable intraluminal graft: a preliminary study: work in progress. Radiology. 1985:156;73-7. doi:10.1148/radiology.156.1.3159043.Palmaz J, Windeler S, Garcia F, et al. Atherosclerotic rabbit aortas: expandable intraluminal grafting. Radiology. 1986;160;723-6. doi:10.1148/radiology.160.3.2942964.Palmaz J, Windeler S, Garcia F, et al. Atherosclerotic rabbit aortas: expandable intraluminal grafting. Radiology. 1986;160;723-6. doi:10.1148/radiology.160.3.2942964.Pavithran S, Bhattacharjya S, Chandrasekaran R, et al. Stent angioplasty of narrowed right ventricular outflow conduits and pulmonary arteries consistently reduces right ventricular systolic pressures and delays subsequent surgeries. Indian Heart J. 2018;70(6):879-86. doi:10.1016/j.ihj.2018.04.010.Pavithran S, Bhattacharjya S, Chandrasekaran R, et al. Stent angioplasty of narrowed right ventricular outflow conduits and pulmonary arteries consistently reduces right ventricular systolic pressures and delays subsequent surgeries. Indian Heart J. 2018;70(6):879-86. doi:10.1016/j.ihj.2018.04.010.Białkowski J, Szkutnik M, Fiszer R, et al. Percutaneous dilatation of coarctation of the aorta, stenotic pulmonary arteries or homografts, and stenotic superior vena cava using Andrastents XL and XXL. Kardiol Pol. 2011;69(12):1213-9.Białkowski J, Szkutnik M, Fiszer R, et al. Percutaneous dilatation of coarctation of the aorta, stenotic pulmonary arteries or homografts, and stenotic superior vena cava using Andrastents XL and XXL. Kardiol Pol. 2011;69(12):1213-9.Lewis M, Kennedy K, Ginns J, et al. Procedural Success and Adverse Eventsin Pulmonary Artery Stenting. J Am Coll Cardiol. 2016;67(11):1327-35. doi:10.1016/j.jacc.2016.01.025.Lewis M, Kennedy K, Ginns J, et al. Procedural Success and Adverse Eventsin Pulmonary Artery Stenting. J Am Coll Cardiol. 2016;67(11):1327-35. doi:10.1016/j.jacc.2016.01.025.McElhinney D, Marshall A, Schievano S. Fracture of Cardiovascular Stents in Patients With Congenital Heart Disease. Circ Cardiovasc Interv. 2013;6:575-85. doi:10.1161/circinterventions.113.000148.McElhinney D, Marshall A, Schievano S. Fracture of Cardiovascular Stents in Patients With Congenital Heart Disease. Circ Cardiovasc Interv. 2013;6:575-85. doi:10.1161/circinterventions.113.000148.Ferraz Cavalcanti P, Sá M, Santos C, et al. Pulmonary valve replacement after operative repair of tetralogy of Fallot: meta-analysis and meta-regression of 3,118 patients from 48 studies. J Am Coll Cardiol. 2013 Dec 10;62(23):2227-43. doi:10.1016/j.jacc.2013.04.107.Ferraz Cavalcanti P, Sá M, Santos C, et al. Pulmonary valve replacement after operative repair of tetralogy of Fallot: meta-analysis and meta-regression of 3,118 patients from 48 studies. J Am Coll Cardiol. 2013 Dec 10;62(23):2227-43. doi:10.1016/j.jacc.2013.04.107.Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403-5. doi:10.1016/s0140-6736(00)02844-0.Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403-5. doi:10.1016/s0140-6736(00)02844-0.Bonhoeffer P, Boudjemline Y, Qureshi S, et al. Percutaneous insertion of the pulmonary valve. J Am Coll Cardiol. 2002;39:1664-9. doi:10.1016/S0735-1097(02)01822-3.Bonhoeffer P, Boudjemline Y, Qureshi S, et al. Percutaneous insertion of the pulmonary valve. J Am Coll Cardiol. 2002;39:1664-9. doi:10.1016/S0735-1097(02)01822-3.Tarek S, Reida E, Khalid Al, et al. Extended Application of Percutaneous Pulmonary Valve Implantation. J Am Coll Cardiol. 2009;53(20):1859-63. doi:10.1016/j.jacc.2008.08.061.Tarek S, Reida E, Khalid Al, et al. Extended Application of Percutaneous Pulmonary Valve Implantation. J Am Coll Cardiol. 2009;53(20):1859-63. doi:10.1016/j.jacc.2008.08.061.Meadows J, Moore P, Berman D, et al. Use and performance of the Melody Transcatheter Pulmonary Valve in native and postsurgical, nonconduit right ventricular outflow tracts. Circ Cardiovasc Interv. 2014;7(3):374-80. doi:10.1161/circinterventions.114.001225.Meadows J, Moore P, Berman D, et al. Use and performance of the Melody Transcatheter Pulmonary Valve in native and postsurgical, nonconduit right ventricular outflow tracts. Circ Cardiovasc Interv. 2014;7(3):374-80. doi:10.1161/circinterventions.114.001225.Nordmeyer J, Khambadkone S, Coats L, et al. Risk stratification, systematic classification, and anticipatory management strategies for stent fr acture after percutaneous pulmonary valve implantation. Circulation. 2007;115:1392-7. doi:10.1161/CIRCULATIONAHA.106.674259.Nordmeyer J, Khambadkone S, Coats L, et al. Risk stratification, systematic classification, and anticipatory management strategies for stent fr acture after percutaneous pulmonary valve implantation. Circulation. 2007;115:1392-7. doi:10.1161/CIRCULATIONAHA.106.674259.Nordmeyer J, Ewert P, Gewillig M, et al. Acute and midterm outcomes of the postapproval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur Heart J. 2019;40(27):2255-64. doi:10.1093/eurheartj/ehz201.Nordmeyer J, Ewert P, Gewillig M, et al. Acute and midterm outcomes of the postapproval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur Heart J. 2019;40(27):2255-64. doi:10.1093/eurheartj/ehz201.Eicken A, Schubert S, Hager A, et al. Percutaneous trcuspid valve implantation: two-center experience with midterm results. Circ Cardiovasc Interv. 2015;8(4):e002155. doi:10.1161/circinterventions.114.002155.Eicken A, Schubert S, Hager A, et al. Percutaneous trcuspid valve implantation: two-center experience with midterm results. Circ Cardiovasc Interv. 2015;8(4):e002155. doi:10.1161/circinterventions.114.002155.Eicken A, Ewert P, Hager A, et al. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J. 2011;27;32(10):1260-5. doi:10.1093/eurheartj/ehq520.Eicken A, Ewert P, Hager A, et al. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J. 2011;27;32(10):1260-5. doi:10.1093/eurheartj/ehq520.Khambadkone S, Coats L, Taylor A, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation. 2005;112(8):1189-97. doi:10.1161/circulationaha.104.523266.Khambadkone S, Coats L, Taylor A, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation. 2005;112(8):1189-97. doi:10.1161/circulationaha.104.523266.Callahan R, Bergersen L, Baird C, et al. Mechanism of valve failure and efficacy of reintervention through catheterization in patients with bioprosthetic valves in the pulmonary position. Ann Pediatr Cardiol. 2017;10(1):11-7. doi:10.4103/0974-2069.197049.Callahan R, Bergersen L, Baird C, et al. Mechanism of valve failure and efficacy of reintervention through catheterization in patients with bioprosthetic valves in the pulmonary position. Ann Pediatr Cardiol. 2017;10(1):11-7. doi:10.4103/0974-2069.197049.Jhaveri S, Prieto L, Suntharos P. Hammock effect and complete cusp prolapse: Rare mechanisms of Melody valve failure demonstrated by intracardiac echocardiography. Ann Pediatr Cardiol. 2019;12(3):342-4. doi:10.4103/apc.APC_143_18.Jhaveri S, Prieto L, Suntharos P. Hammock effect and complete cusp prolapse: Rare mechanisms of Melody valve failure demonstrated by intracardiac echocardiography. Ann Pediatr Cardiol. 2019;12(3):342-4. doi:10.4103/apc.APC_143_18.Zahn E, Hellenbrand W, Lock J, et al. Implantation of the Melody transcatheter pulmonary valve in patients with dysfunctional right ventricular outflow tract conduits: early results from the U.S. clinical trial. J Am Coll Cardiol. 2009;54(18):1722-9. doi:10.1016/j.jacc.2009.06.034.Zahn E, Hellenbrand W, Lock J, et al. Implantation of the Melody transcatheter pulmonary valve in patients with dysfunctional right ventricular outflow tract conduits: early results from the U.S. clinical trial. J Am Coll Cardiol. 2009;54(18):1722-9. doi:10.1016/j.jacc.2009.06.034.Kenny D, Hijazi Z, Kar S, et al. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol. 2011;58(21):2248. doi:10.1016/j.jacc.2011.07.040.Kenny D, Hijazi Z, Kar S, et al. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol. 2011;58(21):2248. doi:10.1016/j.jacc.2011.07.040.Morgan G, Sadeghi S, Salem M, et al. SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without “pre-stenting”: A multi-institutional experience. Catheter Cardiovasc Interv. 2019;93(2):324. doi:10.1002/ccd.27932.Morgan G, Sadeghi S, Salem M, et al. SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without “pre-stenting”: A multi-institutional experience. Catheter Cardiovasc Interv. 2019;93(2):324. doi:10.1002/ccd.27932.Webb J, Wood D, Ye J, et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation. 2010;121(16):1848-57. doi:10.1161/CIRCULATIONAHA.109.924613.Webb J, Wood D, Ye J, et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation. 2010;121(16):1848-57. doi:10.1161/CIRCULATIONAHA.109.924613.Kenny D, Morgan G, Murphy M, et al. Use of 65 cm large caliber Dryseal sheaths to facilitate delivery of the Edwards SAPIEN valve to dysfunctional right ventricular outflow tracts. Catheter Cardiovasc Interv. 2019;94:409. doi:10.1002/ccd.28409.Kenny D, Morgan G, Murphy M, et al. Use of 65 cm large caliber Dryseal sheaths to facilitate delivery of the Edwards SAPIEN valve to dysfunctional right ventricular outflow tracts. Catheter Cardiovasc Interv. 2019;94:409. doi:10.1002/ccd.28409.Garay F, Webb J, Hijazi Z. Percutaneous replacement of pulmonary valve using the Edwards-Cribier percutaneous heart valve: first report in a human patient. Catheter Cardiovasc Interv. 2006;67(5):659-62. doi:10.1002/ccd.20753.Garay F, Webb J, Hijazi Z. Percutaneous replacement of pulmonary valve using the Edwards-Cribier percutaneous heart valve: first report in a human patient. Catheter Cardiovasc Interv. 2006;67(5):659-62. doi:10.1002/ccd.20753.Kenny D, Rhodes J, Fleming G, et al. 3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial. JACC Cardiovasc Interv. 2018;11(19):1920-9. doi:10.1016/j.jcin.2018.06.001.Kenny D, Rhodes J, Fleming G, et al. 3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial. JACC Cardiovasc Interv. 2018;11(19):1920-9. doi:10.1016/j.jcin.2018.06.001.Sinha S, Aboulhosn J, Asnes J, et al. Initial results from the off-label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: A multi-institutional experience. Catheter Cardiovasc Interv. 2019;93(3):455. doi:10.1002/ccd.27973.Sinha S, Aboulhosn J, Asnes J, et al. Initial results from the off-label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: A multi-institutional experience. Catheter Cardiovasc Interv. 2019;93(3):455. doi:10.1002/ccd.27973.Husain J, Praichasilchai P, Gilbert Y, et al. Early European experience with the Venus P-valve: filling the gap in percutaneous pulmonary valve implantation. EuroIntervention. 2016;12(5):e643-51. doi:10.4244/EIJV12I5A105.Husain J, Praichasilchai P, Gilbert Y, et al. Early European experience with the Venus P-valve: filling the gap in percutaneous pulmonary valve implantation. EuroIntervention. 2016;12(5):e643-51. doi:10.4244/EIJV12I5A105.Promphan W, Prachasilchai P, Siripornpitak S, et al. Percutaneous pulmonary valve implantation with the Venus P-valve: clinical experience and early results. Cardiol Young. 2016;26(4):698-710. doi:10.1017/S1047951115001067.Promphan W, Prachasilchai P, Siripornpitak S, et al. Percutaneous pulmonary valve implantation with the Venus P-valve: clinical experience and early results. Cardiol Young. 2016;26(4):698-710. doi:10.1017/S1047951115001067.Benson L, Bergersen L, McHenry B. One year outcomes from the early feasibility study of the Harmony transcatheter pulmonary valve. JACC. 2016;68(18):B250. doi:10.1016/j.jacc.2016.09.753.Benson L, Bergersen L, McHenry B. One year outcomes from the early feasibility study of the Harmony transcatheter pulmonary valve. JACC. 2016;68(18):B250. doi:10.1016/j.jacc.2016.09.753.Bergersen L, Benson L, Gillespie M, et al. Harmony Feasibility Trial: acute and short-term outcomes with a self-expanding transcatheter pulmonary valve. JACC Cardiovasc Interv. 2017;10(17):1763-73. doi:10.1016/j.jcin.2017.05.034.Bergersen L, Benson L, Gillespie M, et al. Harmony Feasibility Trial: acute and short-term outcomes with a self-expanding transcatheter pulmonary valve. JACC Cardiovasc Interv. 2017;10(17):1763-73. doi:10.1016/j.jcin.2017.05.034.Benson L, Gillespie M, Bergersen L, et al. Three-Year Outcomes From the Harmony Native Outflow Tract Early Feasibility Study. Circ Cardiovasc Interv. 2020;13(1):e008320. doi:10.1161/CIRCINTERVENTIONS.119.008320.Benson L, Gillespie M, Bergersen L, et al. Three-Year Outcomes From the Harmony Native Outflow Tract Early Feasibility Study. Circ Cardiovasc Interv. 2020;13(1):e008320. doi:10.1161/CIRCINTERVENTIONS.119.008320.Georgiev S, Ewert P, Tanase D, et al. A low residual pressure gradient yields excellent longterm outcome after percutaneous pulmonary valve implantation. JACC Cardiovasc Interv. 2019;12(16):1594-603. doi:10.1016/j.jcin.2019.03.037.Georgiev S, Ewert P, Tanase D, et al. A low residual pressure gradient yields excellent longterm outcome after percutaneous pulmonary valve implantation. JACC Cardiovasc Interv. 2019;12(16):1594-603. doi:10.1016/j.jcin.2019.03.037.Shang X, Chen S, Zhang C, et al. First-in-man implantation of Med-Zenith PT-Valve in right ventricular outflow tract for pulmonary regurgitation. JACC Cardiovasc Interv. 2019;12(19):1989-90. doi:10.1016/j.jcin.2019.07.036.Shang X, Chen S, Zhang C, et al. First-in-man implantation of Med-Zenith PT-Valve in right ventricular outflow tract for pulmonary regurgitation. JACC Cardiovasc Interv. 2019;12(19):1989-90. doi:10.1016/j.jcin.2019.07.036.Kim G, Song M, Bae E, et al. Successful feasibility human trial of a new self-expandable percutaneous pulmonary valve (Pulsta Valve) implantation using knitted nitinol wire backbone and trileaflet α-gal-free porcine pericardial valve in the native right ventricular outflow tract. Circ Cardiovasc Interv. 2018;11(6):e006494. doi:10.1161/circinterventions.118.006494.Kim G, Song M, Bae E, et al. Successful feasibility human trial of a new self-expandable percutaneous pulmonary valve (Pulsta Valve) implantation using knitted nitinol wire backbone and trileaflet α-gal-free porcine pericardial valve in the native right ventricular outflow tract. Circ Cardiovasc Interv. 2018;11(6):e006494. doi:10.1161/circinterventions.118.006494.Kim A, Jung J, Jung S, et al. Early Outcomes of Percutaneous Pulmonary Valve Implantation with Pulsta and Melody Valves: The First Report from Korea. J Clin Med. 2020;9(9):2769. doi:10.3390/jcm9092769.Kim A, Jung J, Jung S, et al. Early Outcomes of Percutaneous Pulmonary Valve Implantation with Pulsta and Melody Valves: The First Report from Korea. J Clin Med. 2020;9(9):2769. doi:10.3390/jcm9092769.Zahn E, Chang J, Amer D, et al. First human implant of the Alterra Adaptive PrestentTM: a new self-expanding device designed to remodel the right ventricular outflow tract. Catheter Cardiovasc Interv. 2018;91(6):1125-9. doi:10.1002/ccd.27581.Zahn E, Chang J, Amer D, et al. First human implant of the Alterra Adaptive PrestentTM: a new self-expanding device designed to remodel the right ventricular outflow tract. Catheter Cardiovasc Interv. 2018;91(6):1125-9. doi:10.1002/ccd.27581.

The authors declare that there are no conflicts of interest present.